Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters: a Randomized Controlled Trial

NCT05029063 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT05029063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05029063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters: a Randomized Controlled Trial
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 3
Overall status
Recruiting
Start date
October 5, 2022
Completion date
December 31, 2027
Enrollment
1,828 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, venous thromboembolism